Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/14/24 21:06 | 2/12/24 | MLYS | Health | Drug | Pharmaceutical Preparations | Samsara Biocapital Gp, LLC | CA | T | 1 | P | 7,500 | 13.50 | 0 | 556 | 12 | 5,075 | I | |||||||||||||||
11/27/23 16:01 | 11/22/23 | MLYS | Health | Drug | Pharmaceutical Preparations | Congleton Jon | PA | DO | CEO | 4 | P | 106 | 9.82 | 0 | 11 | 1 | 1,049 | D | ||||||||||||||
2/16/23 21:00 | 2/14/23 | MLYS | Health | Drug | Pharmaceutical Preparations | Hbm Healthcare Investments (Cayman) Ltd. | E9 | T | 1 | P.d | 5,000 | 16.00 | 0 | 313 | 11 | 3,218 | D | |||||||||||||||
2/16/23 17:04 | 2/14/23 | MLYS | Health | Drug | Pharmaceutical Preparations | Ra Capital Management, L.P. | MA | D | 1 | P.d | 20,000 | 16.00 | 0 | 1,250 | 999% | 1,311 | I | |||||||||||||||
2/16/23 16:54 | 2/14/23 | MLYS | Health | Drug | Pharmaceutical Preparations | Levy Adam Scott | PA | O | CFO,Chie | 1 | P | 100 | 16.00 | 0 | 6 | 2 | 351 | D | ||||||||||||||
2/16/23 16:54 | 2/14/23 | MLYS | Health | Drug | Pharmaceutical Preparations | Akkaraju Srinivas | CA | DT | 1 | P.d | 15,000 | 16.00 | 0 | 938 | 26 | 4,519 | I | |||||||||||||||
2/16/23 16:54 | 2/14/23 | MLYS | Health | Drug | Pharmaceutical Preparations | Slingsby Brian Taylor | M0 | DT | 1 | P.d | 4,000 | 16.00 | 0 | 250 | 3 | 9,195 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |